Long-term efficacy of a tele-health intervention for acute coronary syndrome patients with depression: 12-month results of the MoodCare randomized controlled trial

O'Neil, Adrienne, Taylor, Barr, Hare, David L., Sanderson, Kristy ORCID: https://orcid.org/0000-0002-3132-2745, Cyril, Sheila, Venugopal, Kamalesh, Chan, Bianca, Atherton, John J., Hawkes, Anna, Walters, Darren L. and Oldenburg, Brian (2015) Long-term efficacy of a tele-health intervention for acute coronary syndrome patients with depression: 12-month results of the MoodCare randomized controlled trial. European Journal of Preventive Cardiology, 22 (9). pp. 1111-1120. ISSN 2047-4873

Full text not available from this repository. (Request a copy)

Abstract

Background Depression is common after a cardiac event; however it often remains untreated. Previously, we reported the efficacy and feasibility of a 6-month tele-health programme (MoodCare), which integrates depression management into a cardiovascular disease (CVD) risk reduction programme for Acute Coronary Syndrome (ACS) patients with low mood. Here, we evaluate the long-term efficacy of the programme at 12-month follow-up. Design A two-arm, parallel, randomized design to compare the long-term effects of MoodCare (n = 61) to usual care (UC) (n = 60) at 12 months. Method 121 ACS patients recruited from six hospitals in Victoria and Brisbane, Australia were randomized to a telephone-delivered cognitive behavioural therapy and risk-reduction programme or usual medical care. Mixed-model repeated measurements (MMRM) analysis was applied with results expressed as estimated marginal mean changes in depression and health-related quality of life (HRQOL) outcomes by group. Results After 12 months, treatment effects were observed for those with major depressive disorder (MDD) for PHQ-9 depression (MoodCare: mean score: 6.5; 95% CI: 4.9-8.0 versus UC: 9.3; 95% CI: 7.7-10.9, p = 0.012)) and SF-12 mental health scores (MoodCare: 42.5; 95% CI: 39.8-45.2 versus UC: 36.8; 95% CI: 34.1-39.6, p = 0.005). No beneficial treatment effects were observed in those with no MDD at baseline. Conclusion After 12 months, MoodCare was superior to UC for improving mental health outcomes for those with a clinical diagnosis of major depression. Our findings support the implementation of depression-based interventions for cardiac patients with a clinical diagnosis of depression and provide evidence of longer term efficacy to one year.

Item Type: Article
Uncontrolled Keywords: acute coronary syndrome,cardiac,cognitive behaviour therapy,depression,tele-health,epidemiology,cardiology and cardiovascular medicine,sdg 3 - good health and well-being ,/dk/atira/pure/subjectarea/asjc/2700/2713
Faculty \ School: Faculty of Medicine and Health Sciences > School of Health Sciences
Related URLs:
Depositing User: LivePure Connector
Date Deposited: 10 Jul 2021 00:06
Last Modified: 19 Aug 2022 01:13
URI: https://ueaeprints.uea.ac.uk/id/eprint/80525
DOI: 10.1177/2047487314547655

Actions (login required)

View Item View Item